Literature DB >> 27541275

Prevention of Contrast-Induced Acute Kidney Injury: an Update.

George Chalikias1, Ioannis Drosos2, Dimitrios N Tziakas3.   

Abstract

Contrast-induced acute kidney injury (CI-AKI) is a common complication of intravascular administration of contrast media used in coronary angiography, percutaneous coronary intervention and other diagnostic and interventional procedures. This review article aims at summarizing the published literature regarding the prevention of CI-AKI, by focusing on available high-quality meta-analyses addressing this matter. Apart from adequate hydration, a number of pharmacologic agents have been proposed as potential candidates to be included in the routine preparation, prior to the patient's arrival in the cardiac catheterization laboratory. Among them, statins and N-acetylcysteine appear to be the most extensively studied ones. Throughout this article we present the available data on CI-AKI prevention and provide a critical clinical appraisal, as well as a summary of currently available guidelines.

Entities:  

Keywords:  Acute kidney injury; Contrast induced nephropathy; Contrast media; Coronary angiography; Percutaneous coronary intervention; Prevention

Mesh:

Substances:

Year:  2016        PMID: 27541275     DOI: 10.1007/s10557-016-6683-0

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  11 in total

1.  Diagnosing and treating contrast-induced acute kidney injury in 2017.

Authors:  Vikram Raje; George Feldman; Ion S Jovin
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

2.  Cordyceps sinensis prevents contrast-induced nephropathy in diabetic rats: its underlying mechanism.

Authors:  Kai Zhao; Qiaoying Gao; Chunhui Zong; Lixiu Ge; Jinjin Liu
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

Review 3.  Protective Role for Antioxidants in Acute Kidney Disease.

Authors:  Joanne M Dennis; Paul K Witting
Journal:  Nutrients       Date:  2017-07-07       Impact factor: 5.717

4.  The Role of Xuefu Zhuyu Decoction in Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention.

Authors:  Jingjing Zhao; Huahua Liu; Buyun Xu; Jiahao Peng; Yangbo Xing; Weiliang Tang; Fang Peng
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-27       Impact factor: 2.629

5.  The role of nuclear factor erythroid-2-related factor 2 expression in radiocontrast-induced nephropathy.

Authors:  Ji Eun Kim; So Yeon Bae; Shin Young Ahn; Young Joo Kwon; Gang Jee Ko
Journal:  Sci Rep       Date:  2019-02-22       Impact factor: 4.379

Review 6.  Mitochondrial Pathophysiology on Chronic Kidney Disease.

Authors:  Patrícia C Braga; Marco G Alves; Anabela S Rodrigues; Pedro F Oliveira
Journal:  Int J Mol Sci       Date:  2022-02-04       Impact factor: 5.923

7.  Melatonin Alleviates Contrast-Induced Acute Kidney Injury by Activation of Sirt3.

Authors:  Chunmei Zhang; Mengying Suo; Lingxin Liu; Yan Qi; Chen Zhang; Lin Xie; Xuehui Zheng; Chang Ma; Jingyuan Li; Jianmin Yang; Peili Bu
Journal:  Oxid Med Cell Longev       Date:  2021-05-25       Impact factor: 6.543

8.  High Plasma Exposure of Statins Associated With Increased Risk of Contrast-Induced Acute Kidney Injury in Chinese Patients With Coronary Artery Disease.

Authors:  Liyun Cai; Xue Bai; Heping Lei; Hong Wu; Yong Liu; Qian Zhu; Shanshan Zhang; Yibin Liu; Qiuxiong Lin; Jiyan Chen; Bin Zhang; Guodong He; Qingshan Geng; Min Huang; Shilong Zhong
Journal:  Front Pharmacol       Date:  2018-04-30       Impact factor: 5.810

9.  Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients.

Authors:  Bin Yi; Shaoyan Mo; Yumei Jiang; Dingwu Yi; Jinwen Luo; Xiang Chen; Jian Rong
Journal:  J Interv Cardiol       Date:  2020-09-04       Impact factor: 2.279

10.  Role of serum cystatin C in the prediction of contrast-induced nephropathy after intra-arterial interventions.

Authors:  Zheng-Yu Wang; Yong-Li Wang; Jian Wei; Long Jin; Zhen-Chang Wang
Journal:  Chin Med J (Engl)       Date:  2020-02-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.